Tumor resection fails to better survival in metastatic neuroblastoma

01/31/2013 | Healio

A study in the Journal of Clinical Oncology revealed that primary tumor resection did not improve the five-year, event-free survival in patients with metastatic neuroblastoma. The German researchers said the findings "do not justify aggressive surgery in patients undergoing high-intensity multimodal treatment for metastatic neuroblastoma."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX